bicalutamide has been researched along with Low Bone Density in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Carles Galceran, J; Celma Domenech, A; Lorente Garcia, D; Morote Robles, J; Placer Santos, J; Planas Morin, J; Regis, L; Salvador Lacambra, C; Trilla Herrera, E | 1 |
Mistry, R; Parr, NJ; Wadhwa, VK; Weston, R | 1 |
Broulik, PD; Stárka, L | 1 |
3 other study(ies) available for bicalutamide and Low Bone Density
Article | Year |
---|---|
Bone mass behavior after 1 year of different treatment strategies in prostate cancer patients subjected to androgen deprivation therapy.
Topics: Aged; Aged, 80 and over; Alendronate; Androgen Antagonists; Anilides; Antibodies, Monoclonal, Humanized; Bone Density Conservation Agents; Bone Diseases, Metabolic; Denosumab; Femur Neck; Humans; Leuprolide; Lumbar Vertebrae; Male; Nitriles; Osteoporosis; Prostatic Neoplasms; Radiography; Tosyl Compounds | 2014 |
Long-term changes in bone mineral density and predicted fracture risk in patients receiving androgen-deprivation therapy for prostate cancer, with stratification of treatment based on presenting values.
Topics: Absorptiometry, Photon; Aged; Aged, 80 and over; Androgen Antagonists; Anilides; Bone Density; Bone Diseases, Metabolic; Calcium; Fractures, Bone; Gonadotropin-Releasing Hormone; Humans; Male; Middle Aged; Nitriles; Prospective Studies; Prostatic Neoplasms; Risk Factors; Time Factors; Tosyl Compounds; Vitamin D | 2009 |
Effect of antiandrogens casodex and epitestosterone on bone composition in mice.
Topics: Androgen Antagonists; Anilides; Animals; Bone and Bones; Bone Density; Bone Diseases, Metabolic; Calcium; Epitestosterone; Humans; Luteinizing Hormone; Male; Mice; Nitriles; Orchiectomy; Organ Size; Phosphates; Risk Factors; Seminal Vesicles; Testis; Testosterone; Tosyl Compounds | 1997 |